Evidence map›Paper›PMID 29483197›Full record

ArticleThe Journal of biological chemistry2018

The pseudophosphatase phogrin enables glucose-stimulated insulin signaling in pancreatic β cells.

Seiji Torii, Chisato Kubota, Naoya Saito, Ayumi Kawano, Ni Hou, Masaki Kobayashi, Ryoko Torii, Masahiro Hosaka, Tadahiro Kitamura, Toshiyuki Takeuchi and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. In focus in HCB.Histochemistry and cell biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Hypoxylonol F Isolated fromBiomolecules · 2019
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Seiji ToriiFrom the Biosignal Research Center and storii@gunma-u.ac.jp.
Chisato KubotaFrom the Biosignal Research Center and.
Naoya SaitoFrom the Biosignal Research Center and.
Ayumi KawanoFrom the Biosignal Research Center and.
Ni HouFrom the Biosignal Research Center and.
Masaki KobayashiMetabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371-8512, Japan.
Ryoko ToriiFrom the Biosignal Research Center and.
Masahiro Hosakathe Department of Biotechnology, Akita Prefectural University, Akita 010-0195, Japan.
Tadahiro KitamuraMetabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371-8512, Japan.
Toshiyuki TakeuchiFrom the Biosignal Research Center and.
Hiroshi Gomithe Department of Veterinary Anatomy, College of Bioresource Sciences, Nihon University, Fujisawa, Kanagawa 252-8510, Japan.
Gunma University · JPAkita Prefectural University · JPNihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autocrine insulin signaling is critical for pancreatic β-cell growth and activity and is at least partially controlled by protein-tyrosine phosphatases (PTPs) that act on insulin receptors (IRs). The receptor-type PTP phogrin primarily localizes on insulin secretory granules in pancreatic β cells. We recently reported that phogrin knockdown decreases the protein levels of insulin receptor substrate 2 (IRS2), whereas high-glucose stimulation promotes formation of a phogrin-IR complex that stabilizes IRS2. However, the underlying molecular mechanisms by which phogrin affects IRS2 levels are unclear. Here, we found that relative to wildtype mice, IRS2 levels in phogrin-knockout mice islets decreased by 44%. When phogrin was silenced by shRNA in pancreatic β-cell lines, glucose-induced insulin signaling led to proteasomal degradation of IRS2 via a negative feedback mechanism. Phogrin overexpression in a murine hepatocyte cell line consistently prevented chronic insulin treatment-induced IRS2 degradation.

Indexed as

Signal TransductionAnimalsCell LineFemaleGene SilencingGlucoseInsulinInsulin Receptor Substrate ProteinsInsulin-Secreting CellsMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutProteolysisReceptor-Like Protein Tyrosine Phosphatases, Class 8GlucoseInsulinInsulin Receptor Substrate ProteinsMembrane Proteinsphogrin protein, mouseReceptor-Like Protein Tyrosine Phosphatases, Class 8autocrinecell growthinsulin receptorinsulin receptor substrate 2islet antigenpancreatic isletpeptide hormoneprotein-tyrosine phosphatase 1BROSsecretory granuletyrosine-protein phosphatase (tyrosine phosphatase)

Identifiers

PMID29483197
PMCPMC5912479
OpenAlexW2791982258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.